AtaiBeckley (ATAI) Notes Payables (2021 - 2023)

AtaiBeckley (ATAI) reported Notes Payables of $132.5 million for Q3 2023, down 17.96% on a YoY basis from $161.5 million in Q3 2022, and up 53.36% sequentially from $86.4 million in Q2 2023.

AtaiBeckley (ATAI) Notes Payables (2021 - 2023) Analysis & Trends

AtaiBeckley (ATAI) has 3 years of Notes Payables data on file, last reported at $132.5 million in Q3 2023.

  • For the quarter ending Q3 2023, Notes Payables fell 17.96% year-over-year to $132.5 million; the trailing twelve-month figure through Sep 2023 stood at $132.5 million (down 17.96% YoY), and the FY2022 full-year result was $82.5 million, changed N/A from the prior year.
  • Notes Payables climbed to $132.5 million in Q3 2023, from $86.4 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $228.4 million in Q2 2022 to a low of $38000.0 in Q3 2021.
  • A 3-year average of $107.4 million and a median of $86.4 million in 2023 frame the typical range for Notes Payables.
  • Across the five-year window, Notes Payables surged 585541.03% in 2022 and plunged 69.65% in 2023, its largest moves.
  • Tracing ATAI's Notes Payables over 3 years: stood at $38000.0 in 2021, then surged by 217005.26% to $82.5 million in 2022, then jumped by 60.61% to $132.5 million in 2023.
  • Business Quant data shows ATAI's Notes Payables at $132.5 million in Q3 2023, $86.4 million in Q2 2023, and $64.0 million in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 AtaiBeckley 2.56 Bn 2.56 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2023 132.50 Mn
Jun 30, 2023 86.40 Mn
Mar 31, 2023 64.00 Mn
Dec 31, 2022 82.50 Mn
Sep 30, 2022 161.50 Mn
Jun 30, 2022 228.40 Mn
Mar 31, 2022 210.90 Mn
Sep 30, 2021 38,000.00
Jun 30, 2021 39,000.00